Rixe O, Villano JL, Wesolowski R, Noonan AM, et al. A first-in-human phase 1 study of BXQ-350, a first-in-class sphingolipid metabolism regulator, in patients with advanced/recurrent solid tumors or high-grade gliomas. Clin Cancer Res 2024 Sep 12. doi: 10.1158/1078-0432.CCR-24-1721.
PMID: 39264252